Dataset Information


Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.

ABSTRACT: BACKGROUND: Bone metastases represent a common and severe complication in breast cancer, and the involvement of cancer stem cells (CSCs) in the promotion of bone metastasis is currently under discussion. Here, we used a human-in-mice model to study bone metastasis formation due to primary breast CSCs-like colonisation. METHODS: Primary CD44?CD24? breast CSCs-like were transduced by a luciferase-lentiviral vector and injected through subcutaneous and intracardiac (IC) routes in non-obese/severe-combined immunodeficient (NOD/SCID) mice carrying subcutaneous human bone implants. The CSCs-like localisation was monitored by in vivo luciferase imaging. Bone metastatic CSCs-like were analysed through immunohistochemistry and flow cytometry, and gene expression analyses were performed by microarray techniques. RESULTS: Breast CSCs-like colonised the human-implanted bone, resulting in bone remodelling. Bone metastatic lesions were histologically apparent by tumour cell expression of epithelial markers and vimentin. The bone-isolated CSCs-like were CD44?CD24? and showed tumorigenic abilities after injection in secondary mice. CD44?CD24? CSCs-like displayed a distinct bone tropism signature that was enriched in genes that discriminate bone metastases of breast cancer from metastases at other organs. CONCLUSION: Breast CSCs-like promote bone metastasis and display a CSCs-like bone tropism signature. This signature has clinical prognostic relevance, because it efficiently discriminates osteotropic breast cancers from tumour metastases at other sites.


PROVIDER: S-EPMC3694250 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

| GSE36102 | GEO
2013-11-30 | E-GEOD-36102 | ArrayExpress
1000-01-01 | S-EPMC5653849 | BioStudies
2009-01-01 | S-EPMC6512388 | BioStudies
2017-01-01 | S-EPMC5428978 | BioStudies
1000-01-01 | S-EPMC5386565 | BioStudies
2015-01-01 | S-EPMC4715579 | BioStudies
2020-01-01 | S-EPMC6938539 | BioStudies
2014-01-01 | S-EPMC4138251 | BioStudies
2013-01-01 | S-EPMC3576138 | BioStudies